| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/INFDIS/161.5.999 |
| P698 | PubMed publication ID | 2157774 |
| P2093 | author name string | L M Wahl | |
| S M Wahl | |||
| S S Saini | |||
| S M Banks | |||
| P D Smith | |||
| R A Calderone | |||
| C L Lamerson | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| Candida albicans | Q310443 | ||
| Colony stimulating factor 2 | Q423660 | ||
| P304 | page(s) | 999-1005 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans | |
| P478 | volume | 161 |
| Q40489140 | Biologicals and Hematopoietic Cytokines in Prevention or Treatment of Infections in Immunocompromised Hosts |
| Q36862748 | Colony-Stimulating Factors: Their Biological Activities and Clinical Promise |
| Q36970104 | Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts |
| Q35116259 | Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy |
| Q35071461 | Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy |
| Q35557759 | Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. |
| Q47873822 | Effect of GM-CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: a review |
| Q33655376 | Effect of cytokines on anticryptococcal activity of human microglial cells. |
| Q35553326 | Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis |
| Q33981130 | Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans |
| Q33796341 | Enhanced killing of Candida albicans by human macrophages adherent to type 1 collagen matrices via induction of phagolysosomal fusion |
| Q33606073 | Enhancement of susceptibility of CB-17 mice to systemic candidiasis by poly(I . C)-induced interferon |
| Q71885947 | Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis |
| Q33842816 | GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection |
| Q35546571 | Gamma interferon is not essential in host defense against disseminated candidiasis in mice |
| Q71808689 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces toxoplasmastatic activity of human monocytes via induction of prostaglandin E2 (PGE2) |
| Q77534554 | Granulocyte-macrophage colony-stimulating factor (GM-CSF)-coated implants and their potential for reducing biomaterial-associated infection in neutropenic hosts |
| Q41433309 | Granulocyte-macrophage colony-stimulating factor and the immune system |
| Q42281083 | Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis |
| Q36646145 | Hematologic Effects of AIDS Therapies |
| Q40441448 | Hemopoietic Growth and Inhibitory Factors in Treatment of Malignancies: A review |
| Q37195455 | Immune response to fungal infections |
| Q36713998 | Immunobiology of Hematopoietic Colony-Stimulating Factors: Potential Application to Disease Prevention in the Bovine |
| Q33595302 | Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophage colony-stimulating factor |
| Q34068978 | Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation |
| Q37363595 | Infections in the compromised child |
| Q33747897 | Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. |
| Q73167279 | Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine |
| Q36574240 | Macrophages in resistance to candidiasis |
| Q45107966 | Neutropenia and neoplasia: an overview of the pharmacoeconomics of sargramostim in cancer therapy |
| Q36670422 | Production and function of cytokines in natural and acquired immunity to Candida albicans infection |
| Q71978875 | Role of granulocyte colony-stimulating factor in the treatment of mucormycosis |
| Q35819571 | Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism |
| Q71820316 | The effects of colony stimulating factors on human monocyte cell function |
| Q45114285 | The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary |
| Q35166992 | The use of GM-CSF in AIDS |
| Q35531249 | Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study |
Search more.